Individualized investigational treatment.
SB 237 permits Indiana residents with terminal/serious illnesses to access FDA-unapproved investigational treatments when standard options fail.
SB 237 permits Indiana residents with terminal/serious illnesses to access FDA-unapproved investigational treatments when standard options fail.
WeVote — Public opinion
No community votes yet. Be the first to weigh in from the Vote tab.
Bill text & amendments